Mechanical forces are key modulators of valvulogenic developmental programs. However, the mechanosensitive gene network underlying this process remains unclear. It is well established that contractile and flow forces activate endocardial expression of the transcription factor klf2a during valve morphogenesis. We report two novel transcription factors with a function in heart valve formation in zebrafish: egr1 and klf2b. Genomewide analysis of gene expression reveals that the endocardial transcriptional programs modulated by klf2a, klf2b, and egr1 mainly contain non-redundant targets. Several of these targets have been implicated in endothelial-to-mesenchymal transition (EMT). VEGF receptor 1 (flt1) is a target of egr1 and klf2b during early valvulogenesis. These   findings suggest that klf2a, klf2b, and egr1 cooperate for the activation of EMT program in response to mechanosensitive inputs. We propose that the combinatorial action of these factors mediates flow mechanotransduction to control the endocardial program, especially for valve development.
Introduction
Atrioventricular septal defects (AVSDs) resulting from abnormal fetal and embryonic valve development are the leading cause of Congenital Heart Disease (CHD) [1] . CHD is the most frequently occurring congenital disorder at approximately 1% of live births, with similar prevalence throughout the world (CDC statistics) [2, 3] . Although the diagnosis and treatment of CHDs have significantly improved over recent decades, the complexity of this disorder still represents a challenging medical issue. A complete understanding of the molecular mechanisms governing heart septation and valve development is therefore of particular importance.
In vertebrates, the heart is one of the first organs to be formed. It is well established that the mechanical forces induced by the development of the heart trigger cell signaling events.
Although the mechanisms controlling valve leaflet growth and shape are well known, how those mechanical forces interact with signaling pathways to regulate valve formation remains unclear.
Zebrafish is emerging as an invaluable model system to study the influence of mechanical forces in cardiac valve formation [4] [5] [6] [7] [8] . In zebrafish, the atrioventricular (AV) valves emanate from the endocardial cells (EdCs) [9] . EdCs first cluster at the AV boundary (or atrioventricular canal, AVC) and form an endothelial ring that lines the AV canal between 24 and 48 hpf [4] . This initial clustering is followed by the appearance of cellular extensions towards the extracellular matrix, or cardiac jelly, which is the elastic acellular layer separating myocardium and endocardium [10, 11] . Subsequent tissue remodeling occurs to form multilayered endocardial cushions consisting of ventricular and AVC-derived EdCs within the cardiac jelly, which in turn overlays the atrial-derived EdCs exposed to the lumen [12, 13] .
Heart valve development begins with the formation of cardiac cushions at the sites of future valves [14, 15] . In mouse, cushion formation is initiated with endocardial-mesenchymal transformation (EMT), a process in which endocardial cells delaminate and transform into mesenchymal cells to invade the matrix that separates the endocardial and myocardial cell layers [16] . In zebrafish the hypothesis that heart valve development relies on EMT processes remains to be elucidated. Recent studies describing how migratory cell behaviors are involved in heart valve morphogenesis suggest that EdCs may undergo partial EMT and migrate into the cardiac jelly as a coordinated sheet of cells [12, 13] . Given the clinical potential of stem cellbased valve repair, there is a growing interest in understanding the genetic programs and developmental pathways regulating valve formation [15] . Endocardial cells respond to local signals generated by the myocardium, such as components of the BMP and TGF-β signaling pathways, by delaminating and migrating while undergoing EMT. This complex process also involves inputs from the Notch and Wnt signaling pathways, in addition to Erbb and VEGF signaling operating within the EdCs [17] . Endothelial cell remodeling is usually controlled by VEGF signaling [18, 19] Flt1 is one of the four VEGF receptors in zebrafish. Both zebrafish forms of the receptor (membrane mFlt-1 and soluble sFlt-1) were shown to be essential to establish and maintain angiogenesis within a VEGF-Notch Feedback Loop [20] . In heart, flt1 expression is first detected in the endocardium at 26 hpf, and seems involved in heart development acting upstream of the phospholipase C gamma 1 (PLCgamma1) to control cardiac ventricular contractility [21] . To date, however, VEGF signaling role during cardiac valve formation is unclear and endocardial growth is thought to occur independently of VEGF signaling [22] . Despite the well-established link between EdCs and valve development, how mechanical forces control EMT to modulate valve morphogenesis in vivo remains unclear.
Valve morphogenesis relies on the coordinated interplay between transcription factors and mechanical forces generated by the blood flow [7, 23] . Blood flow is critical for cell shape change and cell migration occurring at the onset of valvulogenesis in the cardiac jelly [24] .
EdCs can sense a variety of biomechanical stimuli that reflect different patterns of blood flow, such as wall and fluid shear stress and transmural pressure and transduce them into internal signals [25] . These signals trigger the activation of flow-responsive genes in specific regions of the valve, including the zinc-finger transcriptional regulator klf2 [24, 26] . Interestingly, KLF transcription factors have been associated with cerebral cavernous malformations (CCM), which are lined by endothelial cells undergoing EMT [27, 28] . However, klf2 expression and function are not restricted to the AVC [24, 25] . Indeed, klf2 also plays a role in ventricular trabeculation [29] and in controlling the shape of endothelial cells located in the ventricle [22] , suggesting that other flow-inducible transcription factors are required in the AV canal to modulate specific AVC cell responses to flow. A possible candidate could be the only paralog of klf2a in zebrafish, klf2b, of unknown function in valve morphogenesis. The stress-activated transcription factor egr1 is expressed in the developing zebrafish AVC, and it is therefore likely to be involved in valvulogenesis [30] . Moreover, egr1 has been associated with pathologic cardiac hypertrophy and atherosclerosis in human adults [31] , and Egr1 protein has been detected in calcified but not normal aortic valve cusps [32] . The potential roles of egr1 and klf2b in cardiac valve formation therefore need to be investigated.
In this study, we uncover a novel function for egr1 and klf2b as mechanosensitive factors during AV valve morphogenesis and identify their downstream transcriptional targets in the endocardium. When compared to klf2a, egr1 and klf2b have a wide range of unique targets involved in different aspects of endocardial signaling, in particular in the regulation of EMT, including WNT, BMP, Notch, and TGF-β pathways. Importantly, we show that chromatin accessibility is differentially affected in egr1 and klf2a mutants. Our results on gene expression and chromatin accessibility suggest that these transcription factors regulate different networks involved in endocardial development. Finally, we identified flt1 as a target of egr1/klf2b but not klf2a and found it is important for early valve morphogenesis. These data uncover the gene networks and signaling pathways that control endocardial response and heart valve morphogenesis downstream of mechanical stimuli.
Results

Egr1 is a flow-responsive gene
We analyzed egr1 expression at the AVC in wild-type (WT) zebrafish embryos during valvulogenesis between 24 and 48 hpf (hours post fertilization). Whole-mount In Situ Hybridization (WISH) revealed that egr1 is expressed in the central nervous system and heart from 30 hpf onwards (S1 Fig) . At 48 hpf, egr1 expression becomes restricted to a small subset of cells at the AV constriction initiation and an additional region in the Out-Flow Tract (OFT) similarly to klf2 a [24] and klf2b (S1 Fig), where the second set of zebrafish valves develop. egr1 expression was maintained at a high level at 72 hpf in the cardiac area (S1 Fig) .
To assess whether egr1 responds to mechanical forces associated with blood flow, we examined egr1 expression in mutants with abnormal blood flow. Lack of troponin T2A in silent heart (sih -/or tnn2a -/-) mutants causes the loss of cardiac contractility and blood flow [33] , whereas the "bloodless" Vlad Tepes mutant (vlt m651 or gata1 -/-) [34] has few to no blood cells at the onset of circulation due to a severe reduction in blood cell progenitors [35] . egr1 expression was absent in silent heart mutants (S2 Fig) and was decreased in Vlad Tepes
Together these results reveal that egr1 is specifically expressed in valveforming areas in the same developmental time-window as klf2a [24] . Moreover, this egr1 expression pattern is dependent on cardiac contractility and blood flow.
Egr1 and klf2b are required for valve formation
Considering their expression patterns in the AVC, we generated klf2b mutants by targeting the first exon to create a premature stop codon (klf2b ig5 ) and used a mutant allele of egr1 ( Figure   1A ) to investigate their function in valvulogenesis. We examined the cardiac phenotype of klf2b ig5 and egr sa64 mutants. We found that 20% of the egr sa64 maternal zygotic mutants exhibited a pericardial edema visible at 72 hpf and 80% survived to adulthood. Homozygous viable adults were also obtained with klf2b ig5 single mutants ( Figure 1A ). We analyzed valve morphology with BodiPy dye staining [13] at 96 hpf, when the AV valve leaflets can be seen extending into the lumen of the AVC in WT. 50% of egr1 sa64 and klf2b ig5 maternal zygotic mutants showed valvular defects similar to those described previously for klf2a ig4 mutants [13] ( Figure 1B and C).
To investigate whether defects in EdCs remodeling cause the AV valve phenotypes, we performed photo-conversion experiments using egr1 mutant and WT embryos expressing a photo-convertible protein in endothelial cells, including the endocardium (Tg(fli1a:Gal4FF, UAS:Kaede) [36] . In WT embryos, EdCs maintain cell-cell contact and form a multilayered structure during valve morphogenesis. egr1 mutants mainly show "clump with mixing" phenotypes, indicating that cell migration during valve morphogenesis is abnormal in these mutants. "Mixed" phenotypes occur when cell adhesion is not properly controlled during cell migration, resulting in mixing of cells from different valve regions. In contrast, in "thick" and "clump" phenotypes, the ability of cells to migrate as a coordinated sheet seems unaffected, but an additional cell layer appears inside the valve leaflet ( Figure 1D and E). The egr1 mutant valve morphology phenotypes suggest a potential role of these factors in regulating the cellular remodeling processes driving mature cushion formation.
egr1, klf2a, and klf2b control diverse transcriptional programs in the endocardium
Since the expression of egr1 and klf2 is restricted to the EdCs that overlie the cardiac jelly, the valve morphology phenotypes of egr1 and klf2 mutants likely reflect perturbations in signaling from the endocardium. To identify these signaling events, we performed RNA-seq in EdCs isolated from 48 hpf egr1 and klf2a and b mutants and control embryos (fli:gal4FF;UAS:Kaede) (Fig 2A) . We chose this time point because egr1, klf2a, and klf2b are all strongly expressed in the AVC. By using a stringent cut-off of 3-fold, we identified 675 upand 719 down-regulated genes (p<0.05) in egr1 mutants (Fig 2B and Supplementary Table 1 ), with down-regulated genes enriched for the categories "heart development" and "heart morphogenesis" (P=3.94E-04 and P=2.2E-03, respectively) ( Fig 2C and Supplementary Table   1 ). Moreover, we identified 485 up-and 1137 down-regulated transcripts in klf2a EdCs (cutoff 3-fold, p<0.05) ( Fig 2B, and Supplementary Table 1 ) with a distinct enrichment for categories such as "embryonic heart tube development" (P=1.04E-04), "heart development" (P=2.36E-04), and "heart morphogenesis", (P=0.033) ( Fig 2C and Supplementary Table 1 ) in the down-regulated genes. Similar experiments in klf2b mutants identified 2369 up-and 652 down-regulated genes more than 3-fold (P<0.05) ( Fig 2B) . Thus, in contrast to klf2a, which mostly activates gene expression, klf2b appears to retain a repressive role. Nevertheless, similar to klf2a mutants, genes involved in "heart development" (P=2E-02) were found exclusively in the down-regulated list ( Fig 2C and Supplementary Table 1 ). These results show that egr1 is both an activator and a repressor of gene expression, whereas klf2a is mostly an activator and klf2b is mostly a repressor. Importantly, genes involved in cardiac development are downregulated in all these mutants.
To further explore the function of egr1 and klf2 in valve morphogenesis, we compared the sets of deregulated genes between the mutants. 47 genes were upregulated (hypergeometric test [HGT] P=4.628E-18) and 99 genes were down-regulated (HGT P=3.114E-31) in both egr1 and klf2a ( Fig 2D) . Additionally, 126 genes were up-regulated (HGT P=1.594E-14) and 55 genes were down-regulated (HGT P=1.417E-15) in both egr1 and klf2b mutants ( Fig 2D) . From the 1622 deregulated genes in klf2a and 3021 genes deregulated in klf2b, 197 genes were common to both datasets (HGT P=6.10E-22). Specifically, 58 genes were up-regulated (HGT P=0.026) and 139 down-regulated (HGT P= 3.663E-64) ( Figure 2D ) in both klf2a and klf2b.
As these KLF factors seem to have opposing roles, we asked whether genes up-regulated in klf2a mutants were down-regulated in klf2b mutants and vice-versa. Only 14 genes were upregulated in klf2a mutants and down-regulated in klf2b, whereas 62 genes were down-regulated in klf2a mutants and up-regulated in klf2b (Supplementary Table 1 ). This comparative transcriptional analysis suggests that despite their similar cardiac development phenotypes, egr1, klf2a and klf2b regulate different gene networks. To further explore this possibility, we compared the datasets between the three mutants using Ingenuity Pathway comparative Analysis (IPA). We first analyzed the canonical pathways enriched in each mutant when compared to the others. Surprisingly, egr1 and klf2a mutants showed similar trends with negative activation z-score, pointing to pathway inhibition, for instance in "Role of NFAT in cardiac hypertrophy" or "VEGF family ligand-receptor interactions". However, klf2b mutants exhibited positive z-score, pointing to activation, in the same pathways ( Fig 2E) . These results suggest an overall trend whereby egr1 and klf2a regulate the same pathways as klf2b but in opposite ways ( Fig 2E) . Moreover, several developmental pathways were affected in the mutants ( Fig 2E) . Additionally, we performed upstream regulator analysis using IPA to discover potential transcription factors that could lie upstream of our deregulated genes lists.
Upstream regulators involved in developmental pathways such as Wnt, BMP, and TGF-β were enriched in all datasets, and these results were confirmed by qPCR for many genes ( Fig 2F and S3A Fig) . Again, this analysis showed similarities between egr1 or klf2a in comparison to klf2b mutants ( Fig 2F) .
Collectively these results show that egr1, klf2a, and klf2b regulate several developmental signaling pathways in cardiac development, and suggest that klf2a has an activator role in contrast to klf2b.
egr1, klf2a, and klf2b control unique valve-related transcriptional programs and developmental signaling pathways
To gain a better mechanistic insight into the function of egr1, klf2a, and klf2b in heart and valve development, we analyzed specific target genes with known roles in these processes.
Considering that genetic compensation can significantly alter gene expression in ZF mutants [37] , we assessed potential crossregulation between egr1, klf2a, and klf2b. Contrary to Rasouli et al. [29] we did not detect significative compensatory expression of klf factors in our klf2 mutants, suggesting that our alleles do not activate genetic compensation [38] . Rather, we found that egr1 was significantly downregulated in klf2b mutants (S3A and Supplementary Table 1 ), potentially explaining some of the shared common targets.
We next focused on the wnt signaling pathway which is key for valve development [12, 26] . We found that 18 genes in the Wnt signaling pathway were deregulated in at least one of the mutants (Fig 3B and Supplementary Table 1 ). Interestingly, there was little overlap of deregulated genes between the mutants, except for wnt9b, which was down-regulated in egr1, klf2a, and klf2b mutants ( Fig 3A and 3B and Supplementary Table 1 ). wnt2ba and wnt10a were both significantly up-regulated in egr1 mutants, while wnt16 was up-regulated in klf2a mutants.
daam2 and wnt5a were the only genes in this pathway up-regulated in klf2b mutants ( Fig 3B and Supplementary Table 1 ). A number of other Wnt-related genes were significantly downregulated in at least one of the three mutants. Thus, although egr1, klf2a, and klf2b converge in activating wnt9b expression, they regulate distinct genes of the Wnt pathway.
Our previous research shows that the major endocardial response during AV valve maturation between 48 and 56 hpf relies on the activation of ECM-related genes [13] .
Consistent with these findings, we found that has2, a key biosynthetic enzyme of the ECM component hyaluronan [39] , was significantly down-regulated in egr1 mutants, however, fibronectin1b (fn1b) was specifically up-regulated ( Fig 3C and TGF-β signaling is a well-known regulator of valve morphogenesis [40] . As expected, a number of TGF-β signaling pathway members were deregulated in egr1, klf2a, and klf2b mutants ( Fig 3D and Supplementary Table 1 ). Moreover, we also identified targets in Notch signaling, which is an essential regulator of valve development and cardiac maturation ( Fig 3E and Supplementary Table 1 ). Interestingly, although Notch receptors, ligands and effectors were deregulated in klf2a and klf2b mutants, these targets were not overlapping. Indeed, klf2b seems to modulate Notch ligands and receptors (dll4 is down-regulated but notch1a and jag1a are up-regulated), whereas klf2a regulates Notch effectors, such as her 3, 6, 9, 4. 3 (all downregulated) ( Fig 3E and Supplementary Table 1 ). Similarly, BMP signaling components and its SMAD effectors were deregulated in klf mutants, but these targets did not fully overlap. For instance, effectors such as bmp2a, 7b, and 7a were down-regulated in klf2a mutants, whereas bmp5 and smad4a were down-regulated in klf2b mutants ( Fig 3F and Supplementary Table 1 ).
Only bmpr1ba was down-regulated in both klf mutants. These results indicate that Klf2a and Klf2b regulate the expression of different genes in the Notch and BMP pathways and therefore have a non-redundant role in cardiac development.
Our Notch pathway target analysis suggests that Klf2a and Klf2b act independently of Egr1. In agreement with these findings, a number of genes in the prostaglandin signaling pathway, which is also involved in modulating valve development in response to mechanical forces [41] , was significantly affected in klf2a and klf2b but not in egr1 mutants (S3C Fig and   Supplementary Table 1 ). Similarly, FGF signaling was abnormal in klf2a and klf2b [29] but minimally affected in egr1 mutants (S3D Fig and Supplementary Table 1 ).
ErbB signaling plays an important role in trabeculation and EMT. Several genes in this pathway coding for tyrosine kinase receptors (erbb3b, 4a, 4b, and 3) were up-regulated in klf2b mutants. Consistent with this, ligands of erbb3 and erbb4, nrg (encoded by nrg2a and nrg2b) required for normal heart trabeculation [42, 43] were up-regulated in klf2b mutants (S3E Fig   and Supplementary Table 1 ). In contrast, these Erb ligands were down-regulated in klf2a mutants (S3E Fig and Supplementary Table 1 ). As these genes have been implicated in EMT, we next examined all the EMT-related genes identified in mouse. Out of 46 deregulated genes in this list, only a single gene was commonly misregulated between klf2a and klf2b (tbx20) or between egr1 and klf2a (msx2a) (S3F Fig) .
Together, these results suggest that whilst Klf2a, Klf2b, and Egr1 share a number of common targets, each of these factors exhibits unique regulatory mechanisms to modulate genes involved in EMT.
egr1 mutants exhibit reduced chromatin accessibility in TGF-b and Wnt pathway-related genes
Given that egr1 and klf2a mutants show specific alterations in gene expression, we asked whether they have defects in chromatin accessibility by using Assay for Transposase-Accessible Chromatin sequencing (ATAC-seq) in isolated endothelial cells ( Fig 4A) . We identified 20383 differential peaks in egr1 and klf2a mutants, when compared to fli:life-act-eGFP controls. 20099 of these peaks exhibited lost or reduced accessibility, and only 284 peaks gained chromatin accessibility sites ( Fig 4B) . The majority of the lost and common peaks were localized around the transcription start site (TSS), in introns, or intergenic regions. However, the few sites that gained accessibility were mostly intergenic ( Figure 4C ). For instance, bmp6, a gene in the BMP signaling pathway, shows decreased accessibility in egr1 mutants ( Fig 4D) .
IPA analysis of the genes that are assigned to the differentially accessible regions (100kb upstream and 25kb downstream of the TSS) revealed enrichment for "cardiac hypertrophy signaling" (P=1.6E-14), "Notch signaling pathway" (P=1E-05) and "Wnt/Ca+ pathway" (P=1E-03) ( Fig 4E and Supplementary Table 2 ). Motif analysis showed that different GATA motifs were highly enriched in the differential peaks ( Fig 4F and Supplementary Table 2 ). To identify potential direct targets of egr1, we searched for the core EGR motif (TGCGTGGGYG) in all the differentially accessible regions. We were able to identify 1600 regions containing this motif (cut-off P=1E-04). After assigning these regions to the closest gene, we obtained a list of 1007 potential egr1 direct targets. GO analysis on this list of genes revealed categories associated with heart development, including "cardiovascular system development" (P=6.3E-03), "heart morphogenesis" (P=9.3E-03), and "Wnt signaling pathway" (P=1.03E-05) ( Supplementary Table 3 ).
To gain a better understanding of the differential occupancy of transcription factors, we performed digital footprinting analysis. We identified 12297 control-specific and 1294 egr1specific footprints assigned to 5081 and 394 genes respectively ( Supplementary Table 4 ). Next, we identified 46 egr1 motif-containing footprints with reduced occupancy in egr1 mutant EdCs when compared to the control ( Fig 4G) . Transcription factor motifs for different developmental pathways, such as SMAD, RBPJ and LEF1 factors, showed reduced occupancy in egr1 mutants (S4A Fig) . These data demonstrate that egr1 mutants exhibit decreased chromatin accessibility in regions containing egr1 motifs, but also in regions with motifs for pathways involved in EMT, in agreement with our RNA-seq results.
We compared our ATAC-seq and RNA-seq results to determine whether chromatin accessibility was associated with gene deregulation. We found an overlap of 404 genes with genes deregulated more than 3-fold, and an overlap of 406 genes with genes deregulated with a 1.5 fold cut-off (HGT p < 5.503e-07) (S4B Fig) . GO analysis of these genes revealed categories involved in "heart development" (P=2E-03) and "heart morphogenesis" (P=2E-03) (S4C Fig) . Importantly, some of these genes were both deregulated and had differences in chromatin accessibility in egr1 mutants, for instance, tgfb2 and tgfbr2a, and bcl9l, which have been associated with the WNT pathway and EMT (S4D Figand Supplementary Table 1 , 2).
Thus, these results suggest that egr1 plays an important role in modulating the TGF-β and Wnt pathways in EdCs.
klf2a mutants have alterations in chromatin accessibility in developmental and heartassociated pathways
Next, we conducted a similar chromatin accessibility analysis in klf2a mutant endothelial cells. We identified 8576 differential peaks with altered accessibility in klf2a mutants, with 7813 lost and 763 gained peaks, when compared to the control (Fig 4H and Supplementary Table 2 ). Notably, genes in various developmental pathways lose accessibility in klf2a mutants ( Fig 4J) . GO analysis showed enrichment in genes of the Wnt (P=3.4E-08), Notch (P=1.7E-06) and BMP (P=3.7E-05) signaling pathways, including wnt5a, wnt3, and axin1/2 for the Wnt signaling pathway, notch1a, notch1b, and jag1a for the Notch signaling pathway, and TGF-β receptors and Smad transcription factors for the BMP signaling pathway (Fig 4K and Supplementary Table 2 ). Analysis of de novo and known motifs in differentially accessible ATAC-seq peaks revealed motifs for transcription factors including SOX (P=1E-116), KLF14 (P=1E-29), and TEAD (P=1E-27) ( Figure 4L and Supplementary Table 2 ). The core KLF motif (CACCC) was found in 299 differentially accessible regions within 249 genes, suggesting they could potentially be direct targets of klf2a. Consistent with this, GO analysis in these genes showed enrichment for developmental pathways such as "Wnt signaling pathway" (P=9E-03) and "Notch signaling pathway" (P=1E-02) ( Supplementary Table 3 ).
Next, we performed footprinting analysis to examine the overlap of transcription factor occupancy between control and klf2a mutants. We detected 10029 lost and 3793 gained footprints in klf2a mutant endothelial cells, which were assigned to 4462 and 1867 genes, respectively ( Supplementary Table 4 ). After mapping sequence motifs corresponding to binding sites for various transcription factors, we analyzed KLF motifs to validate our approach.
As expected, footprints containing the KLF motif showed reduced occupancy in klf2a mutants ( Fig 4M) . Similar results were obtained for footprints of the TGF-β, BMP (SMAD3), and Notch (RBPJ) signaling pathways and GATA4 motif in klf2a mutants (S4E Fig) . Additionally, footprints containing LEF1 motifs, a transcription factor that is primarily involved in the canonical Wnt/β-catenin signaling pathway, were less accessible in klf2a mutants (S4E Fig) .
These results show that chromatin accessibility is altered in klf2a mutants in KLF motifs as well as motifs for transcription factors required for EMT.
As for egr1 mutants, we compared our ATAC-seq and RNA-seq results klf2a mutants to determine whether chromatin accessibility was associated with transcriptional deregulation.
We found an overlap of 328 genes (HGT, P < 4.903e-11) when we selected a 3-fold expression cut-off, and 466 genes (HGT, P < 6.889E-19) with a 1.5 fold cut-off (S4F Fig and   Supplementary Table 2 ). Genes involved in "heart development" (P=9E-03), such as tbx20, tbx2a and hand2, were among these genes. Genes in the Wnt signaling pathway was also Table 2 ). Additionally, EMT genes such as tgfbr1b, bmpr1ab, epb41l5, vasna, tbx20, snai2, nfatc1, isl1, msx2b, and lef1 were significantly deregulated in klf2a mutants and exhibited changes in chromatin accessibility (Supplementary Table 1 ,2). Thus, klf2a is a strong candidate as a direct upstream regulator of elements of the BMP, Notch, and Wnt signaling pathways involved in controlling EMT.
klf2a and egr1 regulate different developmental programs
The above transcriptomic and chromatin accessibility analyses reveal that whilst egr1 and klf2a have different programs, they also share some characteristics at the chromatin level.
To further characterize these similarities in chromatin accessibility, we conducted IPA analysis to compare the genes with differentially accessible regions between egr1 and klf2a mutants.
Interestingly, one of the top canonical pathways in both mutants is "cardiac hypertrophy signaling", but we also found developmental pathways, such as Wnt and Notch (mostly enriched in klf2a mutants), TGF-β signaling pathway (enriched in both mutants), Hippo and BMP signaling pathways (enriched in egr1 mutants) ( Fig 5A) . Additionally, TGFβ1 is enriched as a possible upstream regulator, albeit mostly in klf2a mutants ( Fig 5B) . These findings are consistent with our ATAC-seq data showing that developmental pathways are more enriched in differentially accessible regions in klf2a than in egr1 mutants (Supplementary Table 2 ).
We then compared the differentially accessible regions of egr1 and klf2a mutant endothelial cells. First, we compared the sites that gain accessibility and identified common regions between the mutants. egr1 and klf2a only shared 18 regions that gained accessibility, suggesting these sites are highly specific to each factor ( Fig 5C and 5D and Supplementary   Table 5 ). Second, we compared the regions that lose or have reduced accessibility in the mutants. 3669 sites were lost in both erg1 and klf2a mutants (Fig 5E and Supplementary Table   5 ). These regions can be located around the TSS or in intronic and intergenic regions, revealing they have no preference for genomic location (Fig 5F) . Genes important for developmental pathways, such as jag1a (Notch), tcf7l2 (Wnt), and bmpr1ab (BMP), show loss of accessibility in both mutants ( Fig 5G) . We assigned these common regions between erg1 and klf2a mutants to 2534 genes and identified their known and de novo motifs. Interestingly, EGR1 (P=1E- 24) and SMAD4 (P=1E-15) motifs come up in de novo motif analysis ( Fig 5H) suggesting that some of the regions that lose accessibility could be directly regulated by egr1 and the BMP signaling pathway.
Subsequently, we identified the regions in erg1 and klf2a mutants that exhibit loss or decreased accessibility and are also transcriptionally deregulated. We detected 99 genes when down-regulation was more than 3-fold (HGT P<3.114e-31), and 102 genes when the cut-off was 1.5 fold (HGT P<7.878e-27). The overlap between these genes and the lost ATAC-seq peaks in both mutants was 9 or 10 genes, for a cut-off of 3 or 1.5, respectively. eva1a, irx7, and foxd2 were among these genes. We then performed similar analyses for the genes up-regulated in both klf2a and egr1 mutants. We detected 47 genes with a 3-fold cut-off (HGT P<4.628e-18) and 57 genes with 1.5-fold cut-off (HGT P<1.578e-14). Only one up-regulated gene overlapped between the RNA-seq and ATAC-seq datasets of egr1 and klf2a mutants, and this gene was not relevant for cardiac development. Assuming that some of the direct targets of egr1 and klf2a lie within the regions with altered accessibility, our results suggest that these factors regulate different developmental programs.
egr1 and klf2b regulate VEGF-R1/flt1 gene expression
flt1 is an important regulator of endothelial function and angiogenesis [44] [45] [46] and of EMT during valve development in mammals [47, 48] . Expression of the VEGF receptor flt1 was down-regulated in egr1 and klf2b mutants, but not in klf2a mutants. Moreover, a genomic region ~20kB downstream of the flt1 TSS had reduced accessibility in egr1 mutants (Supplementary Table 2 ). WISH revealed that flt1 is expressed in the heart tube from 30 hpf and becomes restricted to the ventricle and AVC/OFT at 48 hpf ( Figure 6A) . To investigate a possible function for flt1 in valvulogenesis, we analyzed flt1 sa1504 mutants, which have a point mutation in an essential splice site of exon 9. 60% of the maternal zygotic mutants had cardiac edema from 48 hpf, which is indicative of abnormal cardiac development ( Fig 6B) . Indeed, flt1 mutants show some important valve defects at 96 hpf ( Fig 6C and 6D ) similar to those of egr1 and klf mutants. Together, these results indicate that flt1 acts downstream of egr1 and klf2b during valve leaflet maturation.
Discussion
We have identified the gene networks downstream of the transcription factors Klf2a and Egr1, involved in modulating heart valve morphogenesis in response to mechanosensitive stimuli.
Genome-wide analyses suggest that Klf2a, Klf2b, and Egr1 cooperate non-redundantly to regulate EMT-associated genes expression during valve morphogenesis. Interestingly, although Egr1 and Klf2a control the expression of different genes, these genes belong to signaling pathways implicated in remodeling of AV EdCs and cardiac jelly, such as Notch, TGFβ and Wnt. These findings suggest that mechanical forces activate EMT programs through multiple flow-responsive transcription factors, including Egr1 and Klf2a. Such a mechanism could explain the diversity of cellular responses to blood flow in the developing endocardium.
Several of the misregulated EMT-associated genes identified in egr1 and klf2 mutants have previously been involved in modulating EMT processes and in regulating EMT during AVC morphogenesis, including Wnt [12, 26] and VEGF signaling pathways [47, 48] . We show that EMT markers are expressed in ZF EdCs and are differentially regulated by Egr1, Klf2b, and Klf2a. EMT is essential for cardiac valve formation in mouse and has also been associated with vascular diseases, including CCM [49] , pulmonary hypertension [50] , vascular graft remodelling, and atherosclerosis [51] . It has been shown that shear stress can activate EMT targets in endothelial cells [52, 53] and in cushion cells of the outflow tract [54] . Notably, Snail and Twist are both activated in response to shear stress in cultured EC [52] and Twist1 promotes EdCs proliferation [55] . We show here that the zebrafish homologues snail2 and twist1 are misregulated in the EdCs of klf2a mutants, suggesting a link between Klf2a function and EMT in EdCs. klf4 and klf2 are both up-regulated in CCM endothelial cells displaying abnormal EMT [27, 28] , which suggests the expression of these factors needs to be tightly repressed during EMT. Since klf expression is repressed by CCM1 in endocardial cells (Donat et al., 2018), we postulate that a similar regulatory mechanism may occur in the endocardium to control EMT during valve morphogenesis. In addition, our findings further suggest that other regulatory processes may be at play to modulate EMT progression in addition to klf2a. For instance, we found that Klf2b represses a number of genes associated with EMT, such as elements of the FGF pathway and collagens. Similarly, we found that Egr1 regulate genes of the Wnt and Tgf beta pathways that are also associated with EMT. EMT has been suggested to occur during sprouting angiogenesis in tip cells, as they lose apical-basal polarity, delaminate and migrate
[56] and during ZF heart valve morphogenesis [12] . Further work will be needed to determine how the EMT proceed in ZF cardiac valve at the cellular scale, and whether klf2 and egr1 act in all endocardial cells or only in specific cell populations undergoing EMT. Answering these questions would help elucidate the dynamics of gene expression that organise the rapidly changing cellular behaviour driving valve morphogenesis.
Endothelial cell remodeling is key for cardiovascular morphogenesis and is typically controlled by VEGF signaling [18, 19] . Flt1 is one of the four VEGF receptors in zebrafish.
Interestingly, we identified flt1 as an essential downstream target of Egr1 and Klf2b, but not Klf2a. Both zebrafish forms of the receptor (membrane mFlt-1 and soluble sFlt-1) have been shown to be essential for the establishment and maintenance of angiogenesis within a VEGF-Notch feedback loop [20] . In the zebrafish heart, flt1 modulates endothelial cell proliferation and regulates vessels formation [57, 58] and cardiac ventricular contractility [59] . However, the role of VEGF signaling during cardiac valve formation remains unclear, and endocardial growth is thought to occur independently of VEGF signaling in zebrafish [22] . In mouse, VEGF is a negative regulator of EMT transformation during the formation of endocardial cushions [47] . Consistent with this, we found that flt1 expression in the AVC between 30 and 48 hpf mimics the expression pattern of egr1 and klf2a. Moreover, flt1 expression is down-regulated in egr1 and klf2b mutants. Since flt1 is required for AVC valve formation, we hypothesise that flt1 acts as a flow-responsive gene and therefore defines a mechanosensitive axis egr1/klf2b-flt1. Future experiments should address the potential function of flt1 in normal and pathological EMT.
In this study, we paid particular attention to heart-associated developmental pathways and genes implicated in EMT regulation. However, our findings highlight the versatility and multi-functionality of egr1 and klf2a/b. Moreover, our data sets provide a powerful resource for the community to explore other potential roles for these transcription factors. For instance, our RNA-seq analysis on klf2a and klf2b mutant EdCs (and to a lesser extent egr1 mutant EdCs) identify several differentially expressed genes involved in various metabolic processes, and these results were corroborated by the chromatin accessibility analysis. This result raises the exciting possibility that these factors may control EdCs metabolism and, conversely, that EdCs metabolism may play a regulatory role in valve morphogenesis. Finally, calcium signaling another enriched pathway in klf2b mutants. Given that calcium signaling acts downstream of mechanosensitive channels during valve formation [25] , it would be interesting to study the role of calcium during valve formation in the context of klf2b function. Further mining of these datasets should provide new mechanistic insights into the crosstalk between mechanotransduction and heart development.
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Figures and legends
The heatmap density is represented as RPKM (reads per kilobase per million reads) mean score. I, Pie charts depicting the genomic location distribution of the lost (upper), common (middle) and the gained (lower) accessible regions in klf2a mutant endocardial cells compared to control. TSS=transcription start site. J, ATAC-seq gene track depicting a differentially accessible region on lef1 gene. Y-axis represents RPKM. K, Bar graphs of selected gene ontology enriched categories for the differentially accessible ATAC-seq regions in klf2a mutants. X-axis represents p-value. L, Exemplary motifs discovered by motif analysis of the differentially accessible regions in klf2a mutants. M, Average normalized Tn5 insertion profiles around footprinted KLF motif in merged ATAC peaks at control and klf2a mutants. FOS indicates significance versus the control. Footprint numbers are indicated on the top. Insertions on the forward and reverse strands are indicated in red and blue, respectively. Figure 5. egr1 and klf2a have some common targets. A, Heatmap depicting the enriched IPA canonical pathways of genes assigned to differentially accessible regions in egr1 and klf2a mutants. B, IPA upstream regulator analysis of genes assigned to differentially accessible regions in egr1 and klf2a mutants. C, Heatmap depicting regions that gain chromatin accessibility in egr1 and klf2a mutants compared to controls. ATAC signals are centered around ±3 kb of the center of the peak (COP) and grouped into three clusters as indicated. The "gained egr1" cluster includes sites that gain accessibility in egr1 mutants. The "common" cluster represents regions with similar accessibility in both egr1 and klf2a mutant and the "gained klf2a" regions that gained accessibility specifically in the klf2a mutant. The heatmap density is represented as RPKM. D, Pie charts depicting the genomic distribution of the clusters in Figure  5C . E, Heatmap depicting chromatin accessibility on the sites of egr1 and klf2a mutants that lose or have diminished accessibility compared to controls. ATAC signals are centered around ±3 kb of the center of the peak (COP) and grouped into three clusters as indicated. The "lost egr1" cluster includes sites that loose accessibility in egr1 mutants. The "common" cluster represents regions with lost accessibility in both egr1 and klf2a mutant and the "lost klf2a" regions are regions that lost accessibility specifically in the klf2a mutant. The heatmap density is represented as RPKM. F, Pie charts depicting the genomic distribution of the clusters in Figure 5E . G, Gene tracks depicting common chromatin accessibility changes in egr1 and klf2a mutants. The scale of the Y-axis represents RPKM. H, Exemplary motifs from motif analysis on regions that lose or have diminished accessibility in both egr1 and klf2a mutants. foxc1b  tgfbr1b  pdcd4a  bmpr1ab  tgfbr2a  epb41l5  foxa2  bcl9l  foxa1  sfrp2  rbpjb  wnt2  gsc  eomesa  vasna  tbx20  nog3  twist1a  fgf8a  smad4a  erg  has2  wnt16  tsc2  tgfb2  sfrp1b  tgfbr2b  nog2  crb2a  bmp7a  jag1a  sfrp1a  notch1a  il1b  msx2a  heyl  wnt5a  nfatc1  bmp7b  isl1  loxl3a  bmp2a  msx2b  lef1  vegfab  efna1a fold change Gene p.value klf2b -/-egr1 0,17 0,024 erg 0,15 0,014 flt1 0,14 0,0076 gata3 0,06 0,0011 gata5 0,04 3,63E-05 has2 0,15 0,016 tbx20 0,22 0,045 wnt9b 0,2 0,048 egr1 -/-klf2a -/-klf2b -/f l t 1 g a t a 5 h a s 2 w n t 9 b g a t a 5 S o x 1 7 t b x 2 0 w n t 9 b e g r 1 f l t 1 g a t a 5 t b x 2 0 w n t 9 b correlation between genes assigned in differentially accessible regions and differentially expressed genes (FC=Fold cut-off 1.5) between control and egr1 mutant endocardial cells. C, Bar graphs of selected gene ontology enriched categories for the genes that are differentially expressed and exhibit also changes in chromatin accessibility in egr1 mutants. X-axis represents p-value. D, Gene track depicting the deregulated tgfb2 gene that also exhibits changes in chromatin accessibility in control and egr1 mutants. The scale of the Y-axis represents RPKM. E, Average normalized Tn5 insertion profiles around footprinted SMAD, GATA, RBPJ and LEF1 motifs in merged ATAC peaks at control and klf2a mutants. FOS indicates significance versus the control. Footprint numbers are indicated on the top. Insertions on the forward and reverse strands are indicated in red and blue, respectively. F, Venn diagram showing the correlation between genes that are assigned in significantly differentially accessible regions and differentially expressed genes (FC=Fold cut-off 1.5) between control and klf2a mutant endocardial cells. G, Bar graphs of selected gene ontology enriched categories for the genes that are differentially expressed and exhibit also changes in chromatin accessibility in klf2a mutants. X-axis represents p-value. H, Gene track depicting the deregulated her2 gene that also exhibits changes in chromatin accessibility in control and klf2a mutants. The scale of the Yaxis represents RPKM.
Materials and Methods
Zebrafish accession gene numbers
klf2a: ENSDARG00000042667 klf2b: ENSDARG00000040432 egr1: ENSDARG00000037421 flt1: ENSDARG00000019371
Zebrafish husbandry, fish strains and embryo treatments
The zebrafish (Danio rerio) lines used in the experiments were the following: wild-type AB, egr1 sa64 -(ZIRC), klf2a ig4 [13] , klf2b ig5 (further information below), flt1 sa1504 -(ZIRC), pkd2 tc321 or cup mutants from ZIRC, vlt m651 or gata1a [60] , tnnt2a b109 or sih [33] , tg(fli:gal4FF ubs ; UAS:kaede) [61] and Tg(kdrl:mCherry) [62] .
Embryos were staged according to hours (hpf) and days postfertilization (dpf). They were incubated at 28.5°C in 0.3% Danieau medium supplemented 5h after birth with 0.003% (wt/vol) 1-phenyl-2-thiourea (PTU) (Sigma Aldrich) to inhibit pigment formation. All zebrafish strains were maintained at the IGBMC fish facility under standard husbandry conditions (14h light/10h dark cycle). The Animal Experimentation Committee of the Institutional Review Board of IGBMC approved all animal experiments performed in this project.
klf2b ig5 line was generated using a TALEN pair (left and right arms: 5'GGACATGGCTTTACCT-3' and 5'AACGTTTGCAAACCAG-3') were designed to target exon 1 of the klf2b gene and injected into single cell wild-type (AB) first cell. We identified the alleles generated and confirmed that potential targeting events could be transmitted through the germline by out-crossing the F0 fish with AB animals and sequencing genomic DNA from pools of 6 F1 embryos. After screening the first generation, we focused on a 28pb-deletion mutation (5'-GGACATGGCTTTACCTTGCCTTTTGCCT-3') leading to a premature stop codon in klf2b transcript. Studies were performed from F4 fish and later generations, and on transgenic lines resulting of out-crossings. A PCR-based genotyping strategy was established using the following primers to identify the wild-type and mutant alleles, the length of the deletion allowing their visualization directly on a 3%-agarose DNA gel: forward 5'-GGAAAGCGCGTATATTTGGA-3', reverse 5'-CAAGTAGGAAATGCAAGTGT-3' and sequencing forward primer 5'-AGAGCGCACTGTGCCTTATA-3'.
In Situ Hybridization (ISH)
ISH assay was performed as in [63] using the following anti-sense probes: flt1 probe: from a partial cDNA fully sequenced ordered at Science Biosource (IRCYp5023H065D, 9038840 IMAGE ID), pCR4-TOPO plasmid, linearized by NCOI (NEB). Transcription using SP6 polymerase. wnt9b probe: forward primer: 5'-TATTGCCCTCTGCATCCTTC-3' and reverse primer: 5'-TGACATTCAACGTGACAGCA-3'. To optimize the imaging of the heart after staining, in certain cases the embryos were made more transparent using fructose. A first bath in 45%-fructose solution (D-fructose, Sigma, ref F0127) containing 1/100 1-Thioglycerol (Sigma M6145) was performed for 15 min followed by a second bath in 90%-fructose solution from 30min to 1 hours depending the stage of the embryo. Imaging was performed using a Leica M165 macroscope with a TrueChrome Metrics (Tucsen) with a Leica 1.0X objective (10450028).
High throughput dissection of 48hpf-hearts
Hearts were dissected from klf2a ig5 , klf2b ig5 and egr1 sa64 lines in background fli:lifeact-eGFP; kdrl:nls-mcherry and respective control embryos at the desired stage (48hfp) using highthroughput extraction technique, optimized from Lombardo et al. (2015) protocol. Hearts were separated mechanically by pipetting up and down a batch of 200 embryos in culture medium (L-15 Leibovitz, 10% FCS 9150, 1.25mM CaCl2, 800mg/L glucose, 50microg/mL penicillin, 0.05mg/mL streptomycin), medium prepared fresh for each experiment. Hearts were then separated from debris after passages on two different filters: first purification though a 100um nylon cell stainer (Falcon, 352360), and further collection on a pre-separation filter 30um (Miltenyi Biotech). After centrifugation 10 min at 2.5g, culture medium was replaced by cold FACS medium (PBS with 2% Fetal Calf Serum 9150, 1% Penicilline/streptavidine, 1mM EDTA) and final filtration was performed with tip strainers (40um) (Scienceware, Bel-Art, flowmi tip strainers)
Fluorescence-activated cell sorting (FACS)
Further separation of endocardial cells from the other cardiac cell types was achieved directly after heart extraction by FACS. FACSAria Fusion (BD Biosciences) device was used. Cells were sorted on a FITC-A detector and flow cell passed through 70um-nozzle. Sorted cells were collected at 4°C in PBS: 9,5uL cold PBS + 0,24uL RNAsin and immediate freezing in dried ice of 1000 cell-samples for mRNA sequencing assay; or 50uL cold PBS for the samples directly treated after sorting with the transposase for ATACseq assay.
mRNA-sequencing
1000 endocardial cells were collected in 9.4 uL PBS-RNase free supplemented with 0,24uL RNAsin and immediately frozen after FACS sorting in dried ice and stored at -80°C. cDNA transcription was performed using Clontech SMART-Seq v4 Ultra Low Input RNA Kit. Pairedend 100 bp reads for control and experimental samples were generated with Illumina Hiseq 4000. RNA-seq raw sequencing data from zebrafish were trimmed with Trimmomatic (version 0.36) [64] and aligned to zebrafish genome version GRCz10/danRer10, with the tophat algorithm (version 2.1.1) [65] and the use of «--b2-very-sensitive» parameter. Samtools (version 0.1.19) [66] were used for data filtering and file format conversion, while the HT-seq count (version 0.5.4p3.) [67] algorithm was applied to assign aligned reads to exons using the following command line «htseq-count -s no -m intersection -nonempty». Differentially expressed genes were identified with the use of the DESeq R package [68] , and genes with fold change cut-off 1.5 and P-value<0.05 were considered to be differentially expressed (DEGs). Heatmaps that were constructed to depict DEGs or selected genes were generated with R/Bioconductor. A summary of the differentially expressed genes can be found in Supplementary Table 1 .
ATAC-sequencing
After FACS sorting, cells harvested in PBS were treated according to Buenrostro et al. protocol [69] . Transposition reaction and purification were directly performed the day of cell collection, DNA resuspended in Buffer EB from the MinElute kit was stored at -20°C upon further treatment. Custom Nextera PCR Primer were used during PCR amplification to label the samples. Library quality control was done using Bioanalyser, a purification step was performed using MiniELute Qiagen kit and size separation on Agencourt AMPure XP beads (A63882, Beckman Coulter, Inc) to remove PCR Nextera primers.
Sequencing was performed on one lane on Illumina HiSeq 4000 sequencing, Nextera, HS-2x50 millions bases for control and mutants. Bowtie2 algorithm (version 2.1.0) [70] and «--verysensitive» parameter were used for aligning ATAC-seq data to the zebrafish genome version GRCz10/danRer10. Samtools (version 0.1.19) (Li et al., 2009) were used for data filtering and file format conversion. Duplicate reads were removed before peak calling. The MACS2 (version 2.1.0) algorithm [71] was used for ATAC-seq peak identification with default p-value=1-E05. All .bam files were converted to bedgraphs with genomeCoverageBed, a subcommand of BEDTools [72] and MACS2 bdgdiff command was used in order to identify differential enrichment in the accessible regions between control and mutants, with default options. Gene annotation (100 kB upstream and 25kB downstream ftom the TSS) and genomic distribution of accessible regions identified by MACS2 was performed with BEDtools (Quinlan and Hall, 2010) and -closetBed and -intersectBed subcommands were used respectively. Clustering of regions was generated with ComputeMatrix function of DeepTools [73] , using reference point --referencePoint center -b 3000 -a 3000 -R <bed files> -S <bigwig files> as parameters. The function plotHeatmap from the same package was used for displaying the average profiles heatmap. A summary of ATAC-seq peaks can be found in Supplementary  Table 2 .
Gene ontology, pathway and network analysis
Gene ontology and pathway analysis of the differentially expressed genes from RNA-seq and and the genes that were assigned in differential peaks from ATAC-seq was performed with DAVID knowledgebase [74, 75] and Ingenuity Pathway Analysis software (IPA, Ingenuity® Systems, www.ingenuity.com) with the default settings. Only pathways and biological processes with p-value <=0.05 were considered to be significantly enriched.
Motif analysis
Differentially accessible chromatin regions were searched for enriched short-sequence motifs using HOMER software with "findMotifsGenome.pl" command. [76] . To identify potential direct targets of mutants, core motifs were scanned with FIMO (Find Individual Motif Occurrences) [77] , taking 1E-04 as a threshold. A summary of mutant direct targets can be found in Supplementary Table 3 .
Digital genomic footprinting for ATAC-Sequencing
To attain sufficient sequencing depth to perform digital genomic footprinting (DGF) on ATAC-Seq data produced in this work, aligned .bam files were merged using samtools merge (version 1.3.1) (Li et al., 2009) following sorting via samtools merge and subsequently indexed using samtools index. DGF was performed using dnase_footprints of the Wellington pyDNase package (version 0.2.4) [78] on total merged ATAC peaks using -A as a parameter to enable ATAC mode, resulting in coordinate shift 5' and 3' by +4 and -5 bp, respectively. Motif overrepresentation and average profile analyses were performed with dnase_average_profile.py of the Wellington pyDNase package [78] , on WT-only footprints versus all mutant footprints and vice-versa. For footprinting occupancy scores (FOS) between two experiments, a python script from Wellington pyDNase package (wellington_score_heatmap.py) was used and they were computed first by log2 transformation and then performed two-tailed, paired t-test in R, as each value correspond to the same chromosomal region, and not assuming any direction in the relationship between both samples. Gene annotation (100 kB upstream and 30kB downstream ftom the TSS) of the footprints sites was performed with BEDtools and -closetBed subcommand was used. A summary of the footprint analysis can be found in Supplementary  Table 4 .
Venn diagrams
Proportional venn diagrams for overlapping genes were generated with BioVenn (http://www.biovenn.nl/). Statistical significance of the overlap between two groups of genes was calculated with Hypergeometric statistical test. 
Valve imaging
Embryos were incubated with 4mM BODIPY-FL C5-ceramide (Molecular Probes from ThermoFischer, D3521) overnight and then anesthetized with 0.02% Tricaïne (Sigma Aldrich, Saint-Louis, USA) solution and were mounted on Petri dishes embedded in 0.7% low melting point (LMP) agarose (Sigma Aldrich). To visualize the valve shape and to observe their motion, confocal imaging was performed on a Leica SP8 confocal microscope. Images were acquired with a low-magnification water immersion objective (Leica HCX IRAPO L, 25X, N.A. 0.95).
For four-dimensional imaging, time series were acquired at a random time in the cardiac cycle at 35fps for 3 s. The optical plane was moved 2 mm between the z-sections until the whole AVC was acquired. AVC area was visually defined as in (Steed et al., 2016b) . The number of cells within each AVC was analyzed using Imaris software (Bitplane).
AVC photoconversion
Photoconversion was performed at 48 hpf and follow-up imaging experiments were performed at 98 hpf using the protocol described in Chow et al., 2018 (Jove Paper). Briefly, Tg(fli1a:Gal4FF; UAS:Kaede) embryonic hearts were induced to stop beating by treating embryos with 50 mM 2,3-Butanedione monoxime (BDM) (Sigma Aldrich), a myosin inhibitor, for 5-10 minutes. They were then mounted in 0.7% low melting-point agarose supplemented with 50mM BDM to inhibit heart contraction for the duration of the photoconversion procedure. 48hpf-ventricular cells were selected using the Region of Interest tool and exposed to 405 nm light (400 Hz, 25% laser power) using the FRAP module on a SP8 confocal microscope and a Leica HCX IRAPO L, _25, NA0.95 water immersion objective. For each selected region, one pre-bleach frame was acquired, followed by 3-6 bleach pulses with acquisition to convert kaede protein in the illuminated region from its green to red form. A z-stack of the photoconverted heart was then acquired in the standard confocal mode to record the starting point of each experiment. Embryos were then carefully removed from the agarose using a glass suction pipette, washed in fish water, and then placed in fresh fish water containing 0.003 % PTU. Heart contraction soon resumes, and the fish are allowed to develop normally at 28.5 °C under standard conditions until the second timepoint of interest (98hpf).
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